hepatitis E vaccine

Known as: Hep E 
 

Topic mentions per year

Topic mentions per year

2000-2018
0246820002018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND The first commercialized hepatitis E vaccine, HEV 239, has been shown to be safe and highly immunogenic, the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2013
2013
A recombinant hepatitis E vaccine, Hecolin, has been proven safe and effective in healthy adults. As hepatitis B surface antigen… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Seroprevalence data suggest that a third of the world's population has been infected with the hepatitis E virus. Our… (More)
Is this relevant?
2009
2009
The candidate recombinant hepatitis E vaccine, HEV 239, protect monkeys against infection by hepatitis E virus (HEV). The safety… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Hepatitis E virus (HEV) is an important cause of viral hepatitis. We evaluated the safety and efficacy of an HEV… (More)
Is this relevant?
2007
2007
To test the possibility of developing a combined vaccine against hepatitis A and E, groups of mice were immunized with different… (More)
Is this relevant?
2005
2005
It was evaluated its antigenicity, immunogenicity and efficacy of a candidate recombinant hepatitis E virus (HEV) vaccine… (More)
Is this relevant?
2005
2005
A candidate hepatitis E vaccine is composed of amino acids (aa) 112-607 of the 660-aa protein encoded by open reading frame 2… (More)
Is this relevant?
2004
2004
Hepatitis E virus (HEV) is an important causative agent of enterically-transmitted hepatitis. Successful vaccine development is… (More)
Is this relevant?
2003
2003
We have demonstrated that recombinant hepatitis E vaccine suitable for clinical evaluation was highly immunogenic and efficacious… (More)
Is this relevant?